Skip to main content
Erschienen in: Supportive Care in Cancer 8/2012

01.08.2012 | Original Article

Racial disparities in physical and functional domains in women with breast cancer

verfasst von: Alicia J. Morehead-Gee, Lucinda Pfalzer, Ellen Levy, Charles McGarvey, Barbara Springer, Peter Soballe, Lynn Gerber, Nicole L. Stout

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

African-American women are more likely than white women to have functional impairments after breast cancer (BC) surgery; however, no differences were found in self-reported health status surveys at 12+ months postsurgery.

Purpose

This analysis compared white and African-American BC survivors’ (BCS) health status, health-related quality of life, and the occurrence of physical impairments after BC treatment.

Methods

One hundred sixty-six women (130 white, 28 African-American, 8 other) were assessed for impairments preoperatively and at 1, 3, 6, 9, and 12+ months postsurgery. Health status was assessed at 12+ months using the Short Form Health Survey (SF36v2™). Analysis of variance estimated differences between groups for health status and impairment occurrence.

Results

No differences were found between groups for BC type, stage, grade, or tumor size; surgery type; or number of lymph nodes sampled. African-American BCS had more estrogen/progesterone receptor-negative tumors (p < 0.001; p = 0.036) and received radiation more frequently (p = 0.03). More African-American BCS were employed (p = 0.022) and reported higher rates of social activities (p = 0.011) but less recreational activities (p = 0.020) than white BCS. African-American BCS had higher rates of cording (p = 0.013) and lymphedema (p = 0.011) postoperatively. No differences were found in self-reported health status.

Conclusion

In a military healthcare system, where access to care is ubiquitous, there were no significant differences in many BC characteristics commonly attributed to race. African-American women had more ER/PR-negative tumors; however, no other BC characteristics differed between racial groups. African-American women exhibited more physical impairments, although their BC treatment only differed regarding radiation therapy. This suggests that African-American BCS may be at higher risk for physical impairments and should be monitored prospectively for early identification and treatment.
Fußnoten
1
National Institutes of Health (NIH) Protocol 02-CC-0044; National Naval Medical Center (NNMC) Protocol B01-052
 
2
Pero-System Messgerate, Am Tescher Busch 9, D-42327, Wuppertal, Germany
 
3
Detecto Model CN20, Webb City, MO, USA
 
Literatur
1.
Zurück zum Zitat American Cancer Society (2009) Breast cancer facts and figures 2009–2010. American Cancer Society, Atlanta American Cancer Society (2009) Breast cancer facts and figures 2009–2010. American Cancer Society, Atlanta
2.
Zurück zum Zitat Field TS, Buist DS, Doubeni C et al (2005) Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr 35:88–95PubMedCrossRef Field TS, Buist DS, Doubeni C et al (2005) Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr 35:88–95PubMedCrossRef
3.
Zurück zum Zitat Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor. Cancer 109(9):1721–1728PubMedCrossRef Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor. Cancer 109(9):1721–1728PubMedCrossRef
4.
Zurück zum Zitat Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among. Cancer 97(1):134–147PubMedCrossRef Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among. Cancer 97(1):134–147PubMedCrossRef
5.
Zurück zum Zitat Bigby J, Holmes MD (2005) Disparities across the breast cancer continuum. Cancer Causes Control 16(1):35–44PubMedCrossRef Bigby J, Holmes MD (2005) Disparities across the breast cancer continuum. Cancer Causes Control 16(1):35–44PubMedCrossRef
6.
Zurück zum Zitat Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94(7):490–496PubMedCrossRef Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94(7):490–496PubMedCrossRef
7.
Zurück zum Zitat Simon MS, Severson RK (1997) Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol 176(6):S233–S239PubMedCrossRef Simon MS, Severson RK (1997) Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol 176(6):S233–S239PubMedCrossRef
8.
Zurück zum Zitat Paskett ED, Alfano CM, Davidson MA et al (2008) Breast cancer survivors' health-related quality of life: racial differences and comparisons with noncancer controls. Cancer 113(11):3222–3230PubMedCrossRef Paskett ED, Alfano CM, Davidson MA et al (2008) Breast cancer survivors' health-related quality of life: racial differences and comparisons with noncancer controls. Cancer 113(11):3222–3230PubMedCrossRef
9.
Zurück zum Zitat Bowen DJ, Alfano CM, McGregor BA et al (2007) Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 106(1):85–95PubMedCrossRef Bowen DJ, Alfano CM, McGregor BA et al (2007) Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat 106(1):85–95PubMedCrossRef
10.
Zurück zum Zitat Eversley R, Estrin D, Dibble S, Wardlaw L, Pedrosa M, Favila-Penney W (2005) Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum 32(2):250–256PubMedCrossRef Eversley R, Estrin D, Dibble S, Wardlaw L, Pedrosa M, Favila-Penney W (2005) Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum 32(2):250–256PubMedCrossRef
11.
Zurück zum Zitat Janz NK, Mujahid MS, Hawley ST et al (2009) Race/ethnicity, physical activity, and quality of life in breast cancer. J Cancer Surviv 3(4):212–222PubMedCrossRef Janz NK, Mujahid MS, Hawley ST et al (2009) Race/ethnicity, physical activity, and quality of life in breast cancer. J Cancer Surviv 3(4):212–222PubMedCrossRef
12.
Zurück zum Zitat Jatoi I, Becher H, Leake CR (2003) Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system. Cancer 98(5):894–899PubMedCrossRef Jatoi I, Becher H, Leake CR (2003) Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system. Cancer 98(5):894–899PubMedCrossRef
13.
Zurück zum Zitat Halmin M, Bellocco R, Lagerlund M, Karlsson P, Tejler G, Lambe M (2008) Long-term inequalities in breast cancer survival—a ten year follow-up study of patients managed within a National Health Care System (Sweden). Acta Oncol 47(2):216–224PubMedCrossRef Halmin M, Bellocco R, Lagerlund M, Karlsson P, Tejler G, Lambe M (2008) Long-term inequalities in breast cancer survival—a ten year follow-up study of patients managed within a National Health Care System (Sweden). Acta Oncol 47(2):216–224PubMedCrossRef
14.
Zurück zum Zitat Du W, Simon MS (2005) Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 91(3):243–248PubMedCrossRef Du W, Simon MS (2005) Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 91(3):243–248PubMedCrossRef
15.
Zurück zum Zitat Ware JE Jr, Gandek B (1998) Overview of the SF-36 Health Survey and the International Quality of Life. J Clin Epidemiol 51(11):903–912PubMedCrossRef Ware JE Jr, Gandek B (1998) Overview of the SF-36 Health Survey and the International Quality of Life. J Clin Epidemiol 51(11):903–912PubMedCrossRef
16.
Zurück zum Zitat Hawthorne G, Osborne RH, Taylor A, Sansoni J (2007) The SF36 version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res 16(4):661–673PubMedCrossRef Hawthorne G, Osborne RH, Taylor A, Sansoni J (2007) The SF36 version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res 16(4):661–673PubMedCrossRef
17.
Zurück zum Zitat Cella DF (1994) Quality of life: concepts and definition. J Pain Symptom Manage 9(3):186–192PubMedCrossRef Cella DF (1994) Quality of life: concepts and definition. J Pain Symptom Manage 9(3):186–192PubMedCrossRef
18.
Zurück zum Zitat Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112(12):2809–2819PubMedCrossRef Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112(12):2809–2819PubMedCrossRef
19.
Zurück zum Zitat Springer B, Levy E, McGarvey C et al (2010) Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat 120(1):135–147PubMedCrossRef Springer B, Levy E, McGarvey C et al (2010) Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat 120(1):135–147PubMedCrossRef
20.
Zurück zum Zitat Brunelli C, Zecca E, Martini C et al (2010) Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain. Health Qual Life Outcomes 8:42PubMedCrossRef Brunelli C, Zecca E, Martini C et al (2010) Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain. Health Qual Life Outcomes 8:42PubMedCrossRef
21.
Zurück zum Zitat Leduc O, Sichere M, Moreau A et al (2009) Axillary web syndrome: nature and localization. Lymphology 42(4):176–181PubMed Leduc O, Sichere M, Moreau A et al (2009) Axillary web syndrome: nature and localization. Lymphology 42(4):176–181PubMed
22.
Zurück zum Zitat Agrawal A, Ayantunde AA, Cheung KL (2006) Concepts of seroma formation and prevention in breast cancer surgery. ANZ J Surg 76(12):1088–1095PubMedCrossRef Agrawal A, Ayantunde AA, Cheung KL (2006) Concepts of seroma formation and prevention in breast cancer surgery. ANZ J Surg 76(12):1088–1095PubMedCrossRef
23.
Zurück zum Zitat Stanton AW, Northfield JW, Holroyd B, Mortimer PS, Levick JR (1997) Validation of an optoelectronic limb volumeter (Perometer). Lymphology 30(2):77–97PubMed Stanton AW, Northfield JW, Holroyd B, Mortimer PS, Levick JR (1997) Validation of an optoelectronic limb volumeter (Perometer). Lymphology 30(2):77–97PubMed
24.
Zurück zum Zitat Ware JE Jr (1976) SF-36 health survey update. Spine (Phila Pa 1976) 25(24):3130–3139CrossRef Ware JE Jr (1976) SF-36 health survey update. Spine (Phila Pa 1976) 25(24):3130–3139CrossRef
25.
Zurück zum Zitat Albanes D, Conway JM, Taylor PR, Moe PW, Judd J (1990) Validation and comparison of eight physical activity questionnaires. Epidemiology 1(1):65–71PubMedCrossRef Albanes D, Conway JM, Taylor PR, Moe PW, Judd J (1990) Validation and comparison of eight physical activity questionnaires. Epidemiology 1(1):65–71PubMedCrossRef
26.
Zurück zum Zitat Gummesson C, Ward MM, Atroshi I (2006) The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord 7:44PubMedCrossRef Gummesson C, Ward MM, Atroshi I (2006) The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord 7:44PubMedCrossRef
27.
Zurück zum Zitat Elmore JG, Moceri VM, Carter D, Larson EB (1998) Breast carcinoma tumor characteristics in black and white women. Cancer 83(12):2509–2515PubMedCrossRef Elmore JG, Moceri VM, Carter D, Larson EB (1998) Breast carcinoma tumor characteristics in black and white women. Cancer 83(12):2509–2515PubMedCrossRef
28.
Zurück zum Zitat Wojcik BE, Spinks MK, Optenberg SA (1998) Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 82(7):1310–1318PubMedCrossRef Wojcik BE, Spinks MK, Optenberg SA (1998) Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 82(7):1310–1318PubMedCrossRef
29.
Zurück zum Zitat Shiao YH, Chen VW, Scheer WD, Wu XC, Correa P (1995) Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 55(7):1485–1490PubMed Shiao YH, Chen VW, Scheer WD, Wu XC, Correa P (1995) Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 55(7):1485–1490PubMed
30.
Zurück zum Zitat Weiss HA, Brinton LA, Brogan D et al (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73(10):1298–1305PubMedCrossRef Weiss HA, Brinton LA, Brogan D et al (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73(10):1298–1305PubMedCrossRef
31.
Zurück zum Zitat Weinick RM, Zuvekas SH (2000) Experience of primary care by racial and ethnic groups. Med Care 38(4):447–448PubMedCrossRef Weinick RM, Zuvekas SH (2000) Experience of primary care by racial and ethnic groups. Med Care 38(4):447–448PubMedCrossRef
32.
Zurück zum Zitat Phillips JM, Cohen MZ, Moses G (1999) Breast cancer screening and African American women: fear, fatalism, and silence. Oncol Nurs Forum 26(3):561–571PubMed Phillips JM, Cohen MZ, Moses G (1999) Breast cancer screening and African American women: fear, fatalism, and silence. Oncol Nurs Forum 26(3):561–571PubMed
33.
Zurück zum Zitat Williams DR (1996) Race/ethnicity and socioeconomic status: measurement and methodological issues. Int J Health Serv 26(3):483–505PubMedCrossRef Williams DR (1996) Race/ethnicity and socioeconomic status: measurement and methodological issues. Int J Health Serv 26(3):483–505PubMedCrossRef
34.
Zurück zum Zitat Fiscella K, Franks P, Gold MR, Clancy CM (2000) Inequality in quality: addressing socioeconomic, racial, and ethnic disparities. Jama 283(19):2579–2584PubMedCrossRef Fiscella K, Franks P, Gold MR, Clancy CM (2000) Inequality in quality: addressing socioeconomic, racial, and ethnic disparities. Jama 283(19):2579–2584PubMedCrossRef
35.
Zurück zum Zitat Ward E, Jemal A, Cokkinides V et al (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef Ward E, Jemal A, Cokkinides V et al (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef
36.
Zurück zum Zitat Meeske KA, Sullivan-Halley J, Smith AW et al (2009) Risk factors for arm lymphedema following breast cancer diagnosis in Black women. Breast Cancer Res Treat 113(2):383–391PubMedCrossRef Meeske KA, Sullivan-Halley J, Smith AW et al (2009) Risk factors for arm lymphedema following breast cancer diagnosis in Black women. Breast Cancer Res Treat 113(2):383–391PubMedCrossRef
37.
Zurück zum Zitat Hack TF, Kwan WB, Thomas-Maclean RL (2010) et al. Predictors of arm morbidity following breast cancer surgery. Psychooncology 22 Hack TF, Kwan WB, Thomas-Maclean RL (2010) et al. Predictors of arm morbidity following breast cancer surgery. Psychooncology 22
38.
Zurück zum Zitat Helyer LK, Varnic M, Le LW, Leong W, McCready D (2009) Obesity is a risk factor for developing postoperative lymphedema in breast cancer. Breast J 16(1):48–54PubMedCrossRef Helyer LK, Varnic M, Le LW, Leong W, McCready D (2009) Obesity is a risk factor for developing postoperative lymphedema in breast cancer. Breast J 16(1):48–54PubMedCrossRef
39.
Zurück zum Zitat Sagen A, Karesen R, Risberg MA (2009) Physical activity for the affected limb and arm lymphedema after breast cancer. Acta Oncol 48(8):1102–1110PubMedCrossRef Sagen A, Karesen R, Risberg MA (2009) Physical activity for the affected limb and arm lymphedema after breast cancer. Acta Oncol 48(8):1102–1110PubMedCrossRef
40.
Zurück zum Zitat Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. doi:10.1002/cncr.25458 Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. doi:10.​1002/​cncr.​25458
41.
Zurück zum Zitat Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16(7):1959–1972PubMedCrossRef Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16(7):1959–1972PubMedCrossRef
42.
Zurück zum Zitat Swenson KK, Nissen MJ, Leach JW, Post-White J (2009) Case-control study to evaluate predictors of lymphedema after breast cancer surgery. Oncol Nurs Forum 36(2):185–193PubMedCrossRef Swenson KK, Nissen MJ, Leach JW, Post-White J (2009) Case-control study to evaluate predictors of lymphedema after breast cancer surgery. Oncol Nurs Forum 36(2):185–193PubMedCrossRef
43.
Zurück zum Zitat Smith AW, Alfano CM, Reeve BB et al (2009) Race/ethnicity, physical activity, and quality of life in breast cancer. Cancer Epidemiol Biomarkers Prev 18(2):656–663PubMedCrossRef Smith AW, Alfano CM, Reeve BB et al (2009) Race/ethnicity, physical activity, and quality of life in breast cancer. Cancer Epidemiol Biomarkers Prev 18(2):656–663PubMedCrossRef
44.
Zurück zum Zitat Rao D, Debb S, Blitz D, Choi SW, Cella D (2008) Racial/Ethnic differences in the health-related quality of life of cancer. J Pain Symptom Manage 36(5):488–496PubMedCrossRef Rao D, Debb S, Blitz D, Choi SW, Cella D (2008) Racial/Ethnic differences in the health-related quality of life of cancer. J Pain Symptom Manage 36(5):488–496PubMedCrossRef
45.
Zurück zum Zitat Giedzinska AS, Meyerowitz BE, Ganz PA, Rowland JH (2004) Health-related quality of life in a multiethnic sample of breast cancer survivors. Ann Behav Med 28(1):39–51PubMedCrossRef Giedzinska AS, Meyerowitz BE, Ganz PA, Rowland JH (2004) Health-related quality of life in a multiethnic sample of breast cancer survivors. Ann Behav Med 28(1):39–51PubMedCrossRef
46.
Zurück zum Zitat Torres Lacomba M, Mayoral Del Moral O, Coperias Zazo JL, Yuste Sanchez MJ, Ferrandez JC, Zapico Goni A (2009) Axillary web syndrome after axillary dissection in breast cancer: a prospective study. Breast Cancer Res Treat 117(3):625–630PubMedCrossRef Torres Lacomba M, Mayoral Del Moral O, Coperias Zazo JL, Yuste Sanchez MJ, Ferrandez JC, Zapico Goni A (2009) Axillary web syndrome after axillary dissection in breast cancer: a prospective study. Breast Cancer Res Treat 117(3):625–630PubMedCrossRef
47.
Zurück zum Zitat Leidenius M, Leppanen E, Krogerus L, von Smitten K (2003) Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185(2):127–130PubMedCrossRef Leidenius M, Leppanen E, Krogerus L, von Smitten K (2003) Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185(2):127–130PubMedCrossRef
48.
Zurück zum Zitat Ashing-Giwa KT, Padilla G, Tejero J et al (2004) Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina, and Caucasian cancer survivors. Psychooncology 13(6):408–428PubMedCrossRef Ashing-Giwa KT, Padilla G, Tejero J et al (2004) Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina, and Caucasian cancer survivors. Psychooncology 13(6):408–428PubMedCrossRef
Metadaten
Titel
Racial disparities in physical and functional domains in women with breast cancer
verfasst von
Alicia J. Morehead-Gee
Lucinda Pfalzer
Ellen Levy
Charles McGarvey
Barbara Springer
Peter Soballe
Lynn Gerber
Nicole L. Stout
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1285-7

Weitere Artikel der Ausgabe 8/2012

Supportive Care in Cancer 8/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.